Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries.

[1]  J. Yang.  Of markets and rights: Discourse in the 2008 and 2013 Global Action Plan for the Prevention and Control of Noncommunicable Diseases , 2016 .

[2]  J. Yudkin,et al.  Improving global access to medicines for non-communicable diseases. , 2014, The Lancet. Global health.

[3]  W. Vollmer,et al.  Summarising published results from spirometric surveys of COPD: the problem of inconsistent definitions. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[4]  R. Collins,et al.  Prevalence and correlates of airflow obstruction in ∼317 000 never-smokers in China , 2014, European Respiratory Journal.

[5]  H. Leufkens,et al.  Essential medicines for COPD and asthma in low and middle-income countries , 2014, Thorax.

[6]  Michael Brauer,et al.  An Integrated Risk Function for Estimating the Global Burden of Disease Attributable to Ambient Fine Particulate Matter Exposure , 2014, Environmental health perspectives.

[7]  D. Mannino,et al.  Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty—a BOLD analysis , 2013, Thorax.

[8]  Z. Babar,et al.  The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries , 2013, PharmacoEconomics.

[9]  D. Allison,et al.  Heritability of pulmonary function estimated from pedigree and whole-genome markers , 2013, Front. Genet..

[10]  W. Brouwer,et al.  Measuring the affordability of medicines: importance and challenges. , 2013, Health policy.

[11]  L. Myer,et al.  A Systematic Review of the Association between Pulmonary Tuberculosis and the Development of Chronic Airflow Obstruction in Adults , 2013, Respiration.

[12]  U. Keil,et al.  The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: a global synthesis. , 2013, Allergologia et immunopathologia.

[13]  H. Hogerzeil,et al.  Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration , 2013, The Lancet.

[14]  W. Harnett,et al.  Allergy and Parasites , 2013, Journal of parasitology research.

[15]  Bernadette A. Thomas,et al.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[16]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[17]  H. Zar,et al.  Challenges in Treating Pediatric Asthma in Developing Countries , 2012 .

[18]  S. Mendis,et al.  Gaps in Capacity in Primary Care in Low-Resource Settings for Implementation of Essential Noncommunicable Disease Interventions , 2012, International journal of hypertension.

[19]  A. Majeed,et al.  Prevalence of COPD in India: a systematic review. , 2012, Primary care respiratory journal : journal of the General Practice Airways Group.

[20]  A. Buist,et al.  Case-finding options for COPD: results from the Burden of Obstructive Lung Disease Study , 2012, European Respiratory Journal.

[21]  P. Burney,et al.  The use of ethnically specific norms for ventilatory function in African-American and white populations. , 2012, International journal of epidemiology.

[22]  F. Forastiere,et al.  Association of reduced total lung capacity with mortality and use of health services. , 2012, Chest.

[23]  Panos Kanavos,et al.  Is the Brazilian pharmaceutical policy ensuring population access to essential medicines? , 2012, Globalization and Health.

[24]  D. Chisholm,et al.  Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study , 2012, British medical journal.

[25]  A. Buist,et al.  Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project , 2011, European Respiratory Journal.

[26]  S. Hurd,et al.  The GINA Asthma Challenge: reducing asthma hospitalisations , 2011, European Respiratory Journal.

[27]  E. Owusu-Dabo,et al.  Support for smoke-free policy, and awareness of tobacco health effects and use of smoking cessation therapy in a developing country , 2011, BMC public health.

[28]  A. Alwan.  Global status report on noncommunicable diseases 2010. , 2011 .

[29]  国際結核肺疾患予防連合,et al.  The global asthma report 2011 , 2011 .

[30]  D. Beran.  Improving access to insulin: what can be done? , 2011 .

[31]  P. Burney,et al.  Forced vital capacity, airway obstruction and survival in a general population sample from the USA , 2010, Thorax.

[32]  C. Baena-Cagnani,et al.  Regional Variation in Asthma Symptom Prevalence in Latin American Children , 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.

[33]  W. Brouwer,et al.  Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World , 2010, PLoS medicine.

[34]  N. Billo.  Good news: asthma medicines for all. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[35]  Hassan H. Dib,et al.  Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China. , 2010, Health policy and planning.

[36]  Xiaoying Zheng,et al.  Low Birth Weight and Lung Function in Adulthood: Retrospective Cohort Study in China, 1948–1996 , 2010, Pediatrics.

[37]  S. Chapman,et al.  The Global Research Neglect of Unassisted Smoking Cessation: Causes and Consequences , 2010, PLoS medicine.

[38]  S. Montefort,et al.  Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One , 2010, Respiratory research.

[39]  L. Punnett,et al.  National income, self-reported wheezing and asthma diagnosis from the World Health Survey , 2009, European Respiratory Journal.

[40]  S. Gordon,et al.  The burden of COPD in Africa: a literature review and prospective survey of the availability of spirometry for COPD diagnosis in Africa , 2009, Tropical medicine & international health : TM & IH.

[41]  A. Kotwani.  Availability, price and affordability of asthma medicines in five Indian states. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[42]  Michael R. Reich,et al.  Access: How Do Good Health Technologies Get to Poor People in Poor Countries? , 2009 .

[43]  S. Weiland,et al.  Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) , 2009, Thorax.

[44]  D Ross-Degnan,et al.  Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis , 2009, The Lancet.

[45]  H. R. Anderson,et al.  Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three , 2009, Allergy.

[46]  M. Sossa,et al.  Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in children. , 2008, The Cochrane database of systematic reviews.

[47]  P. Burney,et al.  Urban/rural differences in diet and atopy in South Africa , 2008, Allergy.

[48]  J. Potts,et al.  A multinational study of treatment failures in asthma management. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[49]  G. Valdivia,et al.  Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America , 2007, European Respiratory Journal.

[50]  Shengming Liu,et al.  Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. , 2007, American journal of respiratory and critical care medicine.

[51]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[52]  N. Pearce,et al.  Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC) , 2007, Thorax.

[53]  K. Fukino,et al.  The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. , 2007, Bulletin of the World Health Organization.

[54]  H. Zar,et al.  Prevalence of symptoms of asthma, rhinitis and eczema in 13‐ to 14‐year‐old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III , 2007, Allergy.

[55]  D. Enarson,et al.  Access to inhaled corticosteroids is key to improving quality of care for asthma in developing countries , 2007, Allergy.

[56]  D. Strachan,et al.  Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys , 2006, The Lancet.

[57]  Cesar G Victora,et al.  Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study , 2005, The Lancet.

[58]  P. Burney,et al.  Effect of body mass on exercise-induced bronchospasm and atopy in African children. , 2005, The Journal of allergy and clinical immunology.

[59]  A. Buist,et al.  The Burden of Obstructive Lung Disease Initiative (BOLD): Rationale and Design , 2005 .

[60]  Sara Bennett,et al.  For Personal Use. Only Reproduce with Permission from Elsevier Ltd Overcoming Health-systems Constraints to Achieve the Millennium Development Goals , 2022 .

[61]  Noreen M Clark,et al.  Management of chronic disease by patients. , 2003, Annual review of public health.

[62]  H. Steinman,et al.  Bronchial hyper‐responsiveness and atopy in urban, peri‐urban and rural South African children , 2003, Pediatric Allergy and Immunology.

[63]  M. Chapman,et al.  Atopy, asthma, and antibodies to Ascaris among rural and urban children in Kenya. , 2002, The Journal of pediatrics.

[64]  J. Mackay,et al.  The Tobacco Atlas , 2002 .

[65]  J Bousquet,et al.  Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. , 2001, Bulletin of the World Health Organization.

[66]  D. Strachan,et al.  The relationship of per capita gross national product to the prevalence of symptoms of asthma and other atopic diseases in children (ISAAC). , 2001, International journal of epidemiology.

[67]  H. Donson,et al.  Home-made spacers for bronchodilator therapy in children with acute asthma: a randomised trial , 1999, The Lancet.

[68]  R A Kronmal,et al.  Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. , 1998, JAMA.

[69]  D. Barker,et al.  Relation of fetal growth to adult lung function in south India. , 1997, Thorax.

[70]  A. Woodcock,et al.  Exercise induced bronchospasm in Ghana: differences in prevalence between urban and rural schoolchildren. , 1997, Thorax.

[71]  S. Gallivan,et al.  Comparison of the prevalence of reversible airways obstruction in rural and urban Zimbabwean children. , 1991, Thorax.

[72]  E. Weinberg,et al.  Prevalence of asthma: a comparative study of urban and rural Xhosa children , 1979, Clinical allergy.

[73]  H. Anderson,et al.  Respiratory abnormalities in Papua New Guinea children: the effects of locality and domestic wood smoke pollution. , 1978, International journal of epidemiology.

[74]  T. Merrett,et al.  Allergy and parasites: the measurement of total and specific IgE levels in urban and rural communities in Rhodesia , 1976, Clinical allergy.